2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO28] Mini-Oral Session 28　Rare Cancer / Cancer of Unknown Primary 2（Miscellaneous）
【E】

Fri. Feb 18, 2022 3:30 PM - 4:20 PM Room 10 (Royal Room, 1F, The Prince Kyoto Takaragaike)

Chair：Ken-ichi Ito（Division of Breast & Endocrine Surgery, Department of Surgery, Shinshu University），Kazuhiko Sugiyama（Department of Clinical Oncology & Neuro-Oncology Program, Hiroshima University Hospital）

[MO28-3] Efficacy and safety of irinotecan monotherapy and amrubicin monotherapy for platinum-refractory neuroendocrine carcinoma

○Sakura Hiraide1, Shonosuke Wakayama3, Ryunosuke Numakura3, Yuya Yoshida3, Sho Umegaki1, Yoshifumi Kawamura1, Yuki Kasahara1, Kota Ouchi1, Keigo Komine1, Ken Saijo1, Hiroo Imai1, Masahiro Takahashi1,2, Shin Takahashi1, Hidekazu Shirota1, Masanobu Takahashi1,2, Chikashi Ishioka1,2,3 (1.Department of Medical Oncology, Tohoku University Hospital, 2.Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, 3.Department of Clinical Oncology, Tohoku University Graduate School of Medicine)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password